Steve Biko Academic Hospital/University of Pretoria is the first in South Africa to treat liver tumours with sir-spheres microspheres
Recently South African patients have been treated at Steve Biko Academic Hospital, Pretoria, with selective internal radiation therapy (SIRT) in the form of SIR-Spheres microspheres (yttrium-90 resin microspheres; Sirtex Medical Limited, Sydney, Australia) – an innovative form of internal radiotherapy for liver cancers. This form of liver radiotherapy has been shown to be effective in treating patients with different forms of inoperable liver tumours.
Over 5,000 patients are diagnosed with colorectal cancer in South Africa every year.1 In over 40% of colorectal cancer patients the disease will spread to their liver and cannot be removed surgically.2 In addition, around 3,500 South African patients are diagnosed with primary liver cancer every year1 and approximately 85% of these will be inoperable. 3 Patients with inoperable liver tumours often have a poor prognosis even when treated with modern systemic chemotherapy and/or biological agents.
Professor Mike Sathekge, Head of Nuclear Medicine at Steve Biko Academic Hospital and University of Pretoria, said: “Selective Internal Radiation Therapy in the form of yttrium-90 resin microspheres is an exciting innovative radiation treatment for patients with inoperable liver tumours and we are very proud to be the first hospital in South Africa to introduce this form of treatment. The availability of this innovative radio-embolization therapy means new treatment options for patients, and advances in health care for the South African public.’’ These views are shared by Dr Samia Ahmad, the interventional radiologist and the rest of the team.
Selective Internal Radiation Therapy (SIRT), also known as radio-embolization, is a novel treatment for inoperable liver cancer that delivers high doses of radiation directly to the site of tumours. It is a minimally-invasive treatment, in which millions of radioactive microspheres (between 20-60 microns in diameter) are infused via a catheter into the liver, where they selectively target liver tumours with a dose of internal radiation up to 40 times higher than conventional radiotherapy, while sparing healthy tissue. There is growing interest in SIRT using yttrium-90 resin microspheres for the treatment of patients with liver metastases or with primary liver cancer. There is now substantial clinical evidence in comparative studies that SIRT in the form of SIR-Spheres microspheres is an effective and well tolerated therapy for treating patients with previously treated liver metastases from colorectal cancer. There is also mounting evidence that SIRT is an effective and well-tolerated treatment for inoperable primary liver cancer. This is a truly interdisciplinary therapy with nuclear physicians, interventional radiologist, oncologist and surgeons as part of the team.
SIR-Spheres microspheres are approved for use in Australia, the European Union (CE Mark), Switzerland, Turkey and several other countries including in Asia (e.g. India, Korea, Singapore and Hong Kong) for the treatment of inoperable liver tumours.
SIR-Spheres microspheres are also full PMA-approved by the FDA and are indicated in the U.S. for the treatment of non-resectable metastatic liver tumours from primary colorectal cancer in combination with intra-hepatic artery chemotherapy using floxuridine.
A spokesperson from CANSA confirmed that the SIRT service recently launched at Steve Biko Academic Hospital for the treatment of patients with inoperable liver tumours was great news and would allow patients access to a novel therapy which has not routinely been available in South Africa until now.
References:
1. GLOBOCAN 2008. South African Republic estimated incidence of cancer (both sexes). http://globocan.iarc.fr/factsheet.asp#BOTH accessed 25th April 2012.
2. Van Cutsem E, Nordlinger B, Cervantes A and On behalf of the ESMO Guidelines Working Group. Advanced colorectal cancer: ESMO Clinical Practice Guidelines for treatment. Ann Oncol (2010) 21(suppl 5): v93-v97 doi:10.1093/annonc/mdq222.
3. Pleguezuelo M, et al. Expert Rev Gastroenterol Hepatol 2008;2(6):761–84.
Steve Biko Academic Hospital contact details:
Department of Nuclear Medicine
Booking should strictly be done by your treating oncologist following consultation.
Patient Consent form
Tel: +27 12 354 1885/2374
Email: elmarie.wessels@up.ac.za
|
The National Biodiversity and Business Network of South Africa was officially launched at the Gordon Institute of Business Sciences (GIBS) in Sandton on 15 May 2013.
The University of Pretoria was represented by Dr Claudious Chikozho and Ms Anesu Makina, both from Albert Luthuli Centre for Responsible Leadership (ALCRL), as well as Prof Don Cowan from FABI.
.jpg)
I am pleased to inform you that I received many messages conveying positive feedback on the UP Open Day 2013. I was especially pleased about comments that the UP team of staff, students and volunteers was especially helpful and friendly.
My heartfelt appreciation to all who contributed to a positive experience for parents, prospective students, families, school principals and teachers. I encourage you to keep up the good work. Open Day is an important event for the University for attracting good students, and for broadly enhancing the reputation and status of the University.
Staff and students from the Department of Communication Pathology at the University of Pretoria are involved in one of the most important evidence-based interventions for preterm and low birth weight babies in the world.
The final year students are participating in Kalafong Hospital as audiologists and speech-language therapists in this very effective neonatal method to care for preterm and low birth weight babies.
‘Making a choice to enrol at a university, and deciding which university to attend are the most important decisions any young person can make in their lifetime. Therefore, make a good decision: choose the University of Pretoria.’
.jpg)
The University of Pretoria prides itself on its publicly recognised achievements pertaining to its various sporting fraternities. These achievements can be attributed to the University’s sporting facilities, which are of the highest quality among South African universities. To add to its quality achievements, the University of Pretoria, through TuksSport and the High Performance Centre (hpc), has now officially opened a golf training centre.
.jpg)
South African human rights law professor, Christof Heyns, will submit a widely anticipated report on Lethal Autonomous Robots (LARs) to the United Nations (UN) Human Rights Council on 29 May 2013.
Prof Heyns, from the University of Pretoria (UP), was appointed as UN Special Rapporteur on extra-judicial, summary or arbitrary executions in 2010. During last year, he conducted worldwide research on the question whether states should be allowed to use LARs - weapons that, once deployed, can use lethal force without further human intervention - during war, or peace.
The African Union’s New Partnership for Africa’s Development (NEPAD), the United Nations Development Programme (UNDP) and the Albert Luthuli Centre for Responsible Leadership (ALCRL) recently co-hosted a roundtable aimed at establishing a continental leadership transformation programme.
Last edited by: Mariza Vorster